期刊文献+

荧光原位杂交技术在膀胱尿路上皮癌术后随访中的应用

下载PDF
导出
摘要 目的研究荧光原位杂交技术(FISH)在膀胱尿路上皮癌术后随访中的价值。方法膀胱尿路上皮癌术后患者45例,分别于术后3、6、9及12个月行尿液FISH检测、膀胱镜检查及活检,比较FISH检测与膀胱镜检的检测结果。结果 FISH检测的灵敏度为83.3%(5/6),特异度为97.2%(103/106),假阳性率为2.8%(3/106),假阴性率为17.7%(1/6),准确率为94.6%(106/112)。同膀胱镜检比较值=0.60,一致性一般。结论 FISH敏感性高、特异度强、无创伤,在膀胱尿路上皮癌术后随访方面具有重要的价值。
出处 《现代实用医学》 2014年第10期1206-1207,共2页 Modern Practical Medicine
基金 宁波市医学科技计划项目(2011B11)
  • 相关文献

参考文献9

  • 1Jemal A, Siegel R, Ward E, et al. Cancer statisties,2008[J]. CA Caneer J Clin,2008,58 (2):106-130.
  • 2吴阶平.吴阶平泌尿外科学[M].山东科学技术出版社,2009:965.
  • 3Sylvester RJ, Van der Meijden AP, Ooste- rlinck W, et al. Predicting recurrence and progression inindividual Patients with stage Ta TI bladder cancer using EORTC risk tab- les:a combined analysis of 2596 Patients from seven EORTC Irials[J].EurUrol,2006,49: 466-477.
  • 4Kipp BR, Kames R J, Brankley SM, et al. Monitoring intravesical therapy for Super fleial bladder cancer using fluorescence in situ hybridization[J].J Urol,2005,173-401.
  • 5Brausi M, Collette L, Kurth K. Variability in the recurrence rate at first follow-up eystoscopy after TUR in stage Ta TI transitional cell carcinoma of the bladder: a combined analysis of seven EORTC studies[J]. Eur Urol,2002,41:523-553.
  • 6Cheng ZZ, Corey MJ. Complement factor H as a marker for detection of bladder can cer[J]. Clin Chem, 2005,51(5):856-863.
  • 7Chan MW, Chart LW, Tang NL, et al. Hy- permethylation of multiple genes in tumor tissues and voided urine in urinary bladder cancer patients[J]. Clin Cancer Res,2002,8: 464-470.
  • 8Gallucci M, Guadagni F, Marzano R, et al. Status of the p53, p16, RB1, and HER-2 genes and chromosomes 3, 7, 9, and 17 in advanced bladder cancer: correlation with adjacent mucosa and pathological parame ters[J].J Clin Pathol,2005,58(4):367-371.
  • 9曾庆山(综述),汪清(审校).染色体改变与膀胱癌的发生、进展研究[J].医学综述,2009,15(8):1187-1190. 被引量:2

二级参考文献16

  • 1余凯远,翁志梁,李澄棣.尿脱落细胞荧光原位杂交技术诊断膀胱癌的价值[J].国外医学(泌尿系统分册),2005,25(4):449-452. 被引量:6
  • 2Irina AS,Kevin CH,Robert BJ,et al. The development of a multitarget, muhicolor fluorescence in situ hybridization assay for the detection of urothelial carcinoma in urine [ J ]. J Mol Diagn, 2000,2 (3) :116-123.
  • 3Veeramachaneni R, Nordlberg ML, Shi R,et al. Evaluation of fluorescence in situ hybridization as an ancillary tool to urine cytology in diagnosing urothelial carcinoma[ J ]. Diagn Cytopathol,2003,28 (6) :301-307.
  • 4Gallucci M, Guadagni F, Marzano R, et al. Status of the p53, p16, RB1 ,and HER-2 genes and chromosomes 3,7,9, and 17 in advanced bladder cancer:correlation with adjacent mucosa and pathological parameters[ J]. J Clin Pathol,2005,58 (4) :367-371.
  • 5Sauter G, Haley J, Chew K, et al. Epidermal-growth-factor-receptor expression is associated with rapid tumor proliferation in bladder cancer[ J]. Int J Cancer, 1994,57 (4) :508-514.
  • 6Abraham R, Pagano F, Gomella LG, et al. Chromosomal deletions in bladder cancer:shutting down pathways [ J ]. Front Biosci,2007, 12(7) :826-838.
  • 7Placer J, Espinet B, Salido M, et al. Correlation between histologic findings and cytogenetic abnormalities in bladder carcinoma: A FISH study [J]. Adult Urology. 2005,65 ( 6 ) : 913 -918.
  • 8Marano A, Pan Y, Li C, et al. Fluorescence in situ hybridization on bladder washings from patients with bladder cancer[ J ]. Eur Urol, 2000,37(3 ) :358-365.
  • 9Ribal MJ, Alcaraz A, Mengual L, et al. Chromosomal high-polysomies predict tumor progression in T1 transitional cell carcinoma of the bladder[ J]. Eur Urol,2004,45 (5) :593-599.
  • 10Swana HS, Grossman D, Anthony JN, et al. Tumor content of the antiapoptosis molecule survivin and recurrence of bladder cancer [J]. N Engl J Med,1999,341 (6) :452-453.

共引文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部